Klaus Urbahns
Healthcare R&D
Darmstadt, HE, Germany
Darmstadt, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The expanding role for small molecules in immuno-oncology.
Journal: Nature reviews. Drug discovery
Published: July 12, 2022
Stable and Storable N(CF3 )2 Transfer Reagents.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: April 22, 2021
Targeted Covalent Inhibitors for the Treatment of Malaria?
Journal: ACS infectious diseases
Published: October 15, 2020
Small molecules-Giant leaps for immuno-oncology.
Journal: Progress in medicinal chemistry
Published: May 05, 2020
Crystalline Sponges as a Sensitive and Fast Method for Metabolite Identification: Application to Gemfibrozil and its Phase I and II Metabolites.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: March 03, 2020
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies.
Journal: Angewandte Chemie (International ed. in English)
Published: July 31, 2017
Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening.
Journal: Journal of medicinal chemistry
Published: August 05, 2016
2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19.
Journal: ACS medicinal chemistry letters
Published: January 14, 2016
Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore.
Journal: Bioorganic & medicinal chemistry letters
Published: December 22, 2015
Tetrahydro-naphthols as orally available TRPV1 inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: March 04, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026